GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AptarGroup Inc (FRA:AGT) » Definitions » Valuation Rank

AptarGroup (FRA:AGT) Valuation Rank


View and export this data going back to 2008. Start your Free Trial

What is AptarGroup Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

AptarGroup Valuation Rank Related Terms

Thank you for viewing the detailed overview of AptarGroup's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

AptarGroup (FRA:AGT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AptarGroup Inc (FRA:AGT) » Definitions » Valuation Rank
Comparable Companies
RGEN TFX STVN XRAY HAE MMSI NVST AZTA ICUI STAA ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD OCSE:COLO B WST TSE:4543 XSWX:STMN
Traded in Other Exchanges
ATR:USA AGT:Germany
Address
265 Exchange Drive, Suite 301, Crystal Lake, IL, USA, 60014
Website
https://www.aptar.com
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, and closures to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). Aptar's pharmaceutical division generates roughly one third of group sales but over two thirds of group profits.